Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genmab A (GNMSF) Return on Equity (2024 - 2025)

Historic Return on Equity for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to 0.0%.

  • Genmab A's Return on Equity fell 2700.0% to 0.0% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.0%, marking a year-over-year decrease of 2700.0%. This contributed to the annual value of 0.04% for FY2025, which is N/A changed from last year.
  • Per Genmab A's latest filing, its Return on Equity stood at 0.0% for Q4 2025, which was down 2700.0% from 0.3% recorded in Q3 2025.
  • Over the past 5 years, Genmab A's Return on Equity peaked at 0.3% during Q3 2025, and registered a low of 0.0% during Q4 2025.